Company Search:
Advanced Search
Sponsored Links
Precigen Inc Company Snapshot
Precigen Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Precigen Inc with three other companies in this sector in UNITED STATES : Sangamo Therapeutics Inc (2019 sales of $102.43 million of which 100% was Research & Colloboration), Bavarian Nordic AS ($99.19 million of which 100% was pharmaceuticals), and Acceleron Pharma Inc ($73.99 million of which 100% was Bio-pharmaceutical).

Sales Analysis. Precigen Inc reported sales of $90.72 million for the year ending December of 2019. This represents a sharp decrease of 43.5% versus 2018, when the company's sales were $160.57 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Precigen Inc
  Stock Performance Chart for Precigen Inc
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 4.92
(Figures in U.S. Dollars)
1 Week -3.1%   13 Weeks 10.6%  
4 Weeks 18.8%   52 Weeks -23.4%  
Precigen Inc Key Data:
  Ticker: PGEN Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 90,722,000
(Year Ending Jan 2020).
Employees: 857
  Currency: U.S. Dollars Market Cap: 847,646,785
  Fiscal Yr Ends: December Shares Outstanding: 172,285,932
  Share Type: Common Closely Held Shares: 27,160,720
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.